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Summary 
Depleting  thymectomized  mice  of  CD4  +  T  cells,  or  CD4  +  plus  CD8  +  T  cells,  rendered  them 
incapable  of  resolving  Bacillus-Calmette-Guerin  (BCG)  infection  in  their  livers,  spleens,  kidneys, 
and  lungs.  However,  it  did  not  render  them  incapable  of  stabilizing  infection  in  the  latter  three 
organs  after  an  initial  period  of  BCG  growth.  Athymic  nude  mice  showed  a  similar  capacity 
to  control  BCG  growth  in  these  organs  after  a  certain  stage  of  infection.  In  contrast,  congenitally 
severe  combined  immunodeficient  (SCID)  mice  appeared  to  offer  no  resistance  to  BCG  infection, 
in  that  the  organism  grew  progressively  in  all  organs  of  these  mice  and  was  lethal  for  them 
beginning  on  day  55  of  infection.  The  results  suggest  that,  although  CD4  +  T  cells  are  important 
for  resolving  BCG  infection,  an  odB  T  cell-independent  mechanism  of  resistance  can  be  acquired 
at  2-3  wk  of  infection  that  is  capable  of  inhibiting  further  BCG  growth  in  all  organs  except 
the  lungs.  Because  this  mechanism  is  absent  from  SCID  mice,  it  is  likely  that  it  depends  on 
the  functions  of  3~/~  T  cells,  B  cells,  or  both  types  of  cells.  In  keeping  with  this  possibility 
is  the  additional  finding  that  SCID  mice  engrafted  with  lymph  node  cells  depleted  of  CD4  + 
or  CD8  +  T  cells  were  capable  of  expressing  an  appreciable  level  of  resistance  against  BCG 
infection. 
I 
t  is  generally  believed,  on  the  basis  of  results  obtained  from 
adoptive  immunization  and  T  cell  depletion  studies,  that 
immunity  to  infection  with  mycobacteria  is  mediated  by  T 
cells.  It  has  been  known  for  some  time,  for  example,  that 
mice  in  the  process  of  resolving  BCG  infection  acquire  T 
cells  that  are  capable,  on  passive  transfer,  of  conferring  in- 
creased  antimycobacterial  resistance  on  naive  recipient  mice 
(1,  2).  More  recently,  experiments  with  mice  depleted  of  T 
cell  subsets  have  shown  that  depletion  of  CD4  +  T  cells,  but 
not  of  CD8  +  T  cells,  results  in  a  reduced  capacity  to  resolve 
BCG  infection  (3)  and  to  defend  against  infection  with 
Mycobacteriura tuberculosis  (4).  However,  in  the  case  of  BCG 
infection,  the  same  T  cell  depletion  studies  (3)  revealed  that 
the  absence  of  CD4  +  ,  or  both  T  cell  subsets,  did  not  leave 
mice  completely  defensdess  against  infection.  On  the  con- 
trary,  mice  so  depleted  showed  a  surprising  capacity  to  halt 
progressive  growth  of  BCG  after  a  certain  stage  of  infection. 
Therefore,  the  interpretation  that  CD4  +  T  ceils  are  pivotal 
for  resistance  to  BCG  infection  is  not  supported  by  the  evi- 
dence. 
This  paper  will  show  that  mice  depleted  of  CD4  +  plus 
CD8  +  T  ceils,  and  athymic  nude  mice,  can  acquire  the 
ability  to  stabilize  BCG  infection  after  2-3  wk  of  BCG  growth. 
It  will  show,  in  addition,  that  SCID  mice  permit  progressive 
BCG  growth  in  all  organs  and  begin  dying  of  infection  from 
day  55  on,  but  not  if  they  are  engrafted  with  coisogenic  lymph 
node  cells  depleted  of  CD4  +  or  CD8  +  T  ceils.  Therefore, 
acquired  resistance  to  BCG  infection  is  partly  dependent  on 
a  mechanism  that  is  independent  of  CD4  +  and  CD8  + 
T  cells. 
Materials  and  Methods 
Mice.  B6D2FI (C57BL/6  x DBA/2) mice,  BALB/c nu/nu, 
BALB/c nu/+ mice,  CB-17  scid/scid  (SCID) mice,  and  their  coiso- 
genie  CB-17 (H-2  d) counterparts  were used.  All mice were be- 
tween 8 and 9 wk of  age when they  were used  in cxperlments. 
They  were  purchased  from the  Trudeau  Institute  Animal  Breeding 
Facility  and  were  known to  be  free  of  common and  viral  pathogens 
according  to  routine  screening  performed  by the  Research  Diag- 
nostic  Laboratory,  University  of  Missouri.  The SCID mice were 
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T cell-engrafted parents (5). They were maintained in isohtor cages 
supplied with filtered air, and were provided with sterilized food 
and water. Nude mice were maintained under similar conditions. 
BCG.  Mycobacten'um  /an /s, strain BCG Pasteur  (TMC no. 1011), 
was supplied by the Trudeau Institute Culture Collection as a frozen 
mid-log-phase culture. Before each experiment a vial was thawed, 
subjected to brief  ultrasound, and diluted in PBS containing 0.01% 
Tween. It was inoculated in a dose of 2  x  106 CFU in 0.2 rul PBS 
via a lateral tail vein. BCG was enumerated in lungs, livers, spleens, 
and kidneys by plating  10-fold serial dilutions of homogenates of 
these organs on 7Hll agar (Difco Laboratories, Detroit, MI) and 
counting 2-3 wk later. 
T  Cell  Depletion and  Cytofluorometry.  B6D2Ft  mice  were 
thymectomized at 4 wk of age and used in experiments 4 wk later. 
2 d before inoculating BCG the mice were injected with 0.5 mg 
of anti-CD4,  anti-CDS, or both mAbs intravenously. On days 7, 
14, 21, and 32 after BCG inoculation,  mice were again injected 
intravenously with 0.25 mg of these mAbs. The anti-CD4  mAb 
was produced by clone GK1.5 (provided by Frank Fitch, Univer- 
sity of Chicago, Chicago, IL) and the anti-CD8 mAb by clone TIB 
210 (American Type Culture Collection, KockviUe,  MD) growing 
as ascites in immunodepressed mice. Anti-Thy-l.2 mAb was pro- 
duced by clone 30.H.12 (American Type Culture Collection). The 
mAbs were purified as described previously (6). The extent of T 
cell depletion was determined at progressive stages of infection by 
subjecting spleen cells to cytofluorometric analysis on a FACSCan  | 
cytofluorometer (Becton Dickinson & Co., Mountain View, CA) 
after incubating  them in FITC-conjugated  F(ab')2 fragments of 
anti-Thy-l.2, anti-CD4, or anti-CD8 mAb. Preparation of F(ab')2 
fragments and their conjugation to FITC was as described previ- 
ously (6). Dead cells were stained with propidium iodide and ex- 
cluded from calculations done on 3,000 events. 
Engrafting of  SCID Mice with Lymphoid Cells.  In one experiment, 
SCID mice were engrafted with 107 lymph node cells from CB- 
17 mice, or from CB-17 mice depleted of CD4 + T cells or CD8 + 
T cells  by treatment with anti-T cell subset mAbs as described  above. 
The mAbs were given to the CB-17 donors 2 d before harvesting 
their popliteal, axillary,  brachial superior, and mesenteric node cells. 
2 d after infusing SCID recipient mice with CB-17 lymph node 
cells, the recipients were themselves infused with 0.5 mg of the 
appropriate anti-T cell subset mAb to eliminate any T cells that 
survived mAb treatment  in the donors. After a further 3 d, they 
were inoculated intravenously with 2  x  106 BCG, as were appro- 
priate SCID and CB-17 controls. 
Resuks 
Failure of BCG to Crow Progressively in Mice Depleted of T 
Cells with rnAbs.  Fig.  1 shows the growth of BCG in the 
livem spleens, kidneys, and hngs ofimmunocompetent control 
mice, thymectomized control mice, and thymectomized mice 
depleted of CD4 + T  cells alone,  or CD4 + plus CD8 + T 
cells.  It can be seen that after ,x,20 d of BCG growth, im- 
munocompetent mice, but not T ceU-depleted mice, began 
progressively resolving infection in their livers, spleens,  and 
kidneys. However, although incapable of resolving infection 
in  these  organs,  mice  depleted  of CD4 +  or both  T  cell 
subsets were nevertheless capable of preventing further BCG 
growth after day 20 of infection. Consequently, the infec- 
tion was stabilized until the experiment was terminated on 
day 80. This was not the case in the lungs, however, in that 
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Figure 1.  Evidence  that BCG infection  was progressive  in the lungs, 
but not in the kidneys,  livers, and spleens  of  thymectomized  mice  depleted 
of CD4 + (otCD4), or CD4 + plus CD8 + (otCD4 + oeCDS)  T cells, in 
that BCG growth plateaued  in the last-mentioned  organs after  about day 
20 of infection. In contrast, inf~'ction  underwent resolution after about 
day 20 in all organs of immunocompetent  control (CONT) and thymec- 
tomized control (THYM CONT) mice. However, thymectomized  con- 
trols showed  a reduced  ability  to resolve  infection,  which was not reduced 
further by depleting them of CD8 § T cells alone (data not shown). Data 
are means of five mice per group per time point. 
BCG grew progressively in this organ in mice depleted of 
CD4 + or both subsets of T cells while it was being inacti- 
vated in control mice. Fig. I also shows that thymectomized 
control mice were deficient in their capacity to deal with in- 
fection in all organs, in that the rate of resolution of infec- 
tion was slower than in controls. It was found, in addition 
(result not presented), that treating thymectomized mice with 
anti-CD8 did not significantly reduce their ability to resist 
BCG  infection in  any  organ.  Therefore,  CD4 +  T  cells, 
rather than CD8 + T cells, are involved in resolution of BCG 
infection. 
EffTciency ofT Cell Depletion by rnAbt~  The foregoing results 
showing that mice depleted of CD4 + T  cells, or both sub- 
sets of T cells, retain an appreciable capacity to stabilize in- 
fection after "020 d of progressive BCG growth could mean 
that T cell subset depletion was not complete. This was in- 
vestigated by subjecting spleen cells of mAb-treated mice to 
cytofluorometric analysis.  The results in Table 1 show that 
in infected immunocompetent mice and in infected thymec- 
tomized mice, 9.4% and 6.3%, respectively, of spleen cells 
on day 40 of infection were CD4 + T cells. In contrast, only 
0.3-0.4%  of spleen  cells  were  CD4 +  in  thymectomized 
mice repeatedly treated with anti-CD4 mAb or with both 
mAbs. Treatment with both mAbs reduced the number of 
CD8 + T cells to a level that was not detectable by cytofluor- 
ometry. Thus,  it is apparent that depletion of CD4 + and 
CD8 + T cells was essentially complete in terms of the per- 
582  c~/B T Cell-independent Mechanisms of Resistance to Mycobacteria Table  1.  Cytofluororaetric  Assessment of T  Cell Subset Depletion in B6D2FI  Control and Day 40 BCC-infected Mice 
No. of cells in spleen (%) 
Treatment  Thy-l**  CD4*  CD8 +  All ceils 
Uninfected control 
Uninfected thym. control 
Infected control 
Infected thym. control* 
Infected thym. given ,vCD4S 
Infected thym. given otCD4 + ,vCD8  b 
x lO  ~ 
16.7 (15.2)  10.3 (9.38)  5.8 (5.29)  118 
16.8 (11.2)  14.4 (9.6)  7.8 (5.2)  150 
70.8 (13.3)  50.0 (9.4)  17.0 (3.2)  532 
37.4 (10.0)  23.6 (6.3)  9.3 (2.5)  374 
8.3 (4.2)  0.6  (0.3)  7.1 (3.6)  198 
8.5 (2.3)  1.5 (0.4)  -  (0)1t  368 
*  F(ab')z-FITC reagents were  used for cytofluorometry. 
t Thymectomy was performed  when mice were 4 wk old,  4 wk before infection. 
$ 0.5 mg of mAb was given 2 d before infection with 2  x  106 BCG cells, and this was followed by injection of 0.25  mg mAb on days 7,  14, 
21,  and 32. 
Level was below that of detection  using the FACScan  |  cytofluorometer. 
cent that survived, relative to the percent present in controls. 
However, when these results are considered in terms of total 
numbers of ceils, the spleens of anti-CD4-mAb-treated mice 
contained 6  x  10  s CD4 + T  cells, compared with 5  x  107 
in the spleens  of infected immunocompetent controls, and 
2.3  x  107 in the spleens of infected thymectomized controls. 
Therefore, it could be argued that 6  x  10  s CD4 + T  cells 
are enough to inhibit BCG growth as shown in Fig. 1, as- 
suming that a proportion of these cells was, in fact, specific 
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Figure 2.  Evidence that BCG infection was progressive in the lungs, 
but not in the kidneys, livers, and spleens of athymic nude (NU/NU) 
mice. In euthymic (NU/+)  control mice, infection underwent progres- 
sive resolution in all organs beginning  between days 10 and 20 postinocu- 
lation. Data are means of five mice per group per time point. 
for BCG.  It can also be seen in Table 1 that the spleens  of 
infected thymectomized mice depleted of CD4 + and CD8 + 
T  cells contained an appreciable number of Thy-I*CD4 - 
CD8-  cells. 
Ability of Athymic Nude Mice to Acquire Resistance to BCG 
Infection.  As shown above, thymectomized mice repeatedly 
treated with anti-CD4 and anti-CD8 mAbs, although ~,99% 
depleted ofCD4 § and CD8 + T cells on day 40 of infection, 
were nevertheless capable of preventing further growth of 
BCG in their livers, spleens,  and kidneys after day 20 of in- 
fection. It was anticipated, therefore, that the same result 
would be obtained with 8-wk-old athymic nude mice, which 
possess a very small number of ol//3 T cells (7, 8), apparently 
few of which are functionally normal in vivo and in vitro 
(9-11). As shown in Fig. 2, athymic nude mice were capable 
of greatly reducing any further growth of BCG in their livers, 
spleens, and kidneys, although not in their lungs, after about 
day 20 of  infection. This resulted in an approximate phteauing 
of BCG growth in ail organs except the lungs from day 20 
to day 60 of infection when the experiment was terminated. 
In contrast, syngeneic euthymic mice were able to resolve 
infection progressively in all organs starting between days 
10 and 20. 
Progressive Lethal Growth of BCG  in SCID Mice but Not 
in SCID Mice Engrafted with Lymph Node Cells Depleted  of 
CD4 + and CD8 + T  Cells.  The foregoing results show that 
mice depleted of CD4 + and CD8 + T cells, and nude mice, 
can acquire a mechanism of resistance capable of restricting 
the growth of BCG after a certain stage of infection. It could 
be suggested as an argument against this interpretation, how- 
ever, that in the absence of T ceU-mediated immunity BCG 
growth is eventually self limiting in liver, spleen, and kidney, 
but not in lung. This possibility was investigated by following 
the growth of BCG in SCID mice that are devoid of func- 
tional T cells (including 7/~ T cells) and consequently possess 
583  Izzo and North  Brief Definitive Report no  capacity  to  resist  infection  with  a  range  of  pathogenic  and 
nonpathogenic  organisms.  The  results  in  Fig.  3  show  un- 
equivocally  that  BCG  grew  progressively  with  little  inter- 
ruption  in  all  organs  of  SCID  mice  until  the  experiment  was 
terminated  on  day  60.  These  mice  began  dying  of  infection 
after  day  55.  Therefore,  the  growth  of  BCG  in  the  liver,  spleen, 
and  kidney  of  mice  is  not  self  limiting  in  vivo. 
On  the  other  hand,  SCID  mice  engrafted  with  lymph  node 
cells  from  CB-17  donors  were  capable  of  expressing  an  ap- 
preciable  level  of  resistance  against  BCG  infection.  This  was 
the  case,  moreover,  even  with  lymph  node  cells  from  CB-17 
mice  that  had  been  essentially  depleted  of  CD4  +  or  CD8  + 
T  cells.  This  can  be  seen  in  Fig.  4,  which  shows  the  results 
of  an  attempt  to  provide  SCID  mice  with  a  capacity  to  resist 
infection  with  2  x 106  BCG  by  infusing  them  with  107 
lymph  node  cells  from  normal  CB-17  mice  or  from  CB- 
17  mice  depleted  of  CD4  +  or  CD8  +  T  cells  by  treatment 
with  anti-CD4  or  anti-CD8  mAb  2  d  before  transfer.  At  the 
time  of  transfer,  lymph  node  ceils  of  anti-CD4-treated  or  anti- 
CD8-treated  CB-17  donors  contained  <0.1%  CD4  ÷  T  cells 
and  an  undetectable  number  of  CD8  ÷  T  cells,  respectively. 
Moreover,  in  this  experiment,  recipient  SCID  mice  were  them- 
selves  treated  with  anti-CD4  or  anti-CD8  mAbs  in  order  to 
destroy  any  CD4  +  or  CD8  +  T  cells  that  escaped  destruc- 
tion  in  the  donors.  It  is  obvious  from  Fig.  4  that  lymph  node 
cells  depleted  of  CD4  +  T  cells,  although  less  protective  at 
day  40  of  infection  than  total  lymph  node  cells,  nevertheless 
provided  SCID  recipients  with  a  substantial  capacity  to  re- 
sist  infection  in  all  organs  except  the  lungs.  Indeed,  the 
numbers  of  BCG  in  the  organs  of  engrafted  SCID  recip- 
ients  on  day  40  is  in  keeping  with  the  interpretation  that 
recipients  that  had  received  CD4  +  T  cell-depleted  lymph 
node  cells  were  able  to  stabilize  infection,  whereas  recipients 
that  received  total  lymph  node  cells  were  as  capable  as  CD-17 
donor  mice  at  resolving  infection  (see  Fig.  3). 
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Figure  3.  Evidence  that  BCG  infection  was  progressive  in  all  organs 
of  SCID  mice.  In  CB-17  coisogenic  mice,  in  contrast,  infection  under- 
went  progressive  resolution  in  all  organs  after  2-3  wk  of  BCG  growth. 
Discussion 
This  study  shows  that  CD4  ÷  T  cells,  rather  than  CD8  ÷ 
T  cells,  are  needed  by  mice  to  resolve  intravenous  infection 
with  BCG.  However,  it  shows  in  addition,  that  at  a  certain 
stage  of  infection,  mice  depleted  of  CD4  +  T  cells  alone,  or 
of  both  subsets  ofT  cells,  acquired  the  ability  to  prevent  fur- 
ther  growth  of  BCG  in  their  livers,  spleen,  and  kidneys,  al- 
though  not  in  their  lungs,  for  a  protracted  period  of  time. 
A  similar  ability  to  stabilize  infection  was  acquired  by  athymic 
nude  mice.  Stabilization  of  infection  was  not  the  result  of 
self-limiting  growth  of  BCG  in  vivo,  because  the  organism 
grew  progressively  without  interruption  in  all  organs  of  SCID 
mice,  and  was  lethal  for  these  mice  beginning  on  about  day 
55  of  infection.  Therefore,  cells  exist  in  mice  depleted  of 
CD4  ÷  and  CD8  +  T  cells,  and  in  nude  mice,  but  not  in 
SCID  mice,  that  can  stabilize  BCG  infection  after  2-3  wk 
of  progressive  BCG  growth.  Because  "//(5  T  cells  and  B  cells 
are  possessed  by  the  former  mice,  but  not  the  latter,  it  seems 
reasonable  to  suggest  that  either  or  both  of  these  cell  types 
was  involved  in  the  resistance  observed.  A  suggested  role  for 
"r/6  T  cells  is  supported  by  published  evidence  showing  that 
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Figure  4.  Result  of  attempt  to  provide  SCID  mice  with  the  capacity 
to  control  or  resolve  BCG  infection  by  infusing  them  intravenously  with 
107  lymph  node  cells  from  CB-17  mice,  or  from  CB-17  mice  depleted  of 
CD4  ÷  or  CD8  ÷  T  cells  by  treatment  with  anti-CD4  or  anti-CD8  mAbs 
(0.5  rag),  respectively,  2  d  before  death.  In  this  experiment  SCID  recipients 
of  lymph  node  cells  depleted  of  CD4  ÷  ,  or  CD8  +  T  cells,  were  them- 
selves  treated  with  anti-eD4  or  anti-eD8  mAb  (0.5  mg),  respectively, 
2  d  after  cell  transfer,  and  were  inoculated  intravenously  with  2  x  106 
BCG  cells  3  d  later.  Whole  lymph  node  cells  provided  SCID  mice  with 
an  impressive  capacity  to  resist  BeG  infection,  in  that  by  day  40  they  showed 
about  the  same  ability  as  CB-17  donors  to  inactivate  BCG  in  their  lungs, 
kidneys,  livers,  and  spleens.  Lymph  node  cells  depleted  of  CD4  +  T  cells 
showed  a  reduced,  although  appreciable,  capacity  to  protect  SCID  mice 
against  infection  in  their  kidneys,  livers,  and  spleens,  although  not  in  their 
lungs.  Lymph  node  cells  depleted  of  CD8  +  T  cells  were  almost  as  pro- 
tective  as  control  lymph  node  cells.  Data  are  means  of  five  mice  per  group. 
584  c~/3 T  Cell-independent  Mechanisms  of  Resistance  to  Mycobacteria a proportion of 3'/8 T cells are specific for mycobacterial an- 
tigens, including epitopes of the highly conserved 60-kD heat- 
shock protein (12-15). However, a role for B cells also needs 
to be considered, because in spite of past failures to transfer 
antimycobacterial resistance with serum antibodies (16, 17), 
it is possible that these cells  serve to  secrete relevant lym- 
phokines and to act as APC at sites of infection. Studies de- 
signed to investigate the roles of 3'/6 T cells and B cells based 
on lymphocyte engraftment experiments with SCID mice 
are currently in progress in this laboratory. The initial results 
of these studies presented here dearly show that SCID mice 
engrafted with "~107 lymph node cells from naive coisogenic 
CB-17 donors displayed an almost normal capacity to resolve 
BCG infection. These results show, in addition, that an ap- 
preciable level of resistance was expressed in SCID mice en- 
grafted with lymph node cells from CB-17 donors depleted 
of CD4 + or CD8 + T  cells. Indeed, when examined at day 
21 of infection, SCID mice so engrafted contained no detect- 
able CD4 + or CD8 § T cells. Thus, it seems likely that this 
model will allow successful analysis of the cellular basis  of 
antimycobacterial immunity. 
None of the evidence presented here contradicts evidence 
published by others (3, 4) showing that CD4 + T  cells play 
an important role in defense against BCG infection. On the 
contrary, our results support an important role for this subset 
of o~/~ T  cells in resistance to BCG.  However, their main 
purpose is to show that a CD4 + T cell-independent mech- 
anism of defense can be called on by the host to combat in- 
fection with this organism. Indeed, an examination of the 
results ofT cell depletion studies published by others (3) shows 
quite dearly that thymectomized mice treated with anti-CD4 
mAb,  although deficient in their capacity to resolve BCG 
infection, retained a capacity to stabilize infection and to even 
begin resolving infections after a delay.  This is entirely in 
keeping with the data presented here. Unfortunately, it is 
not possible  to  know in  the case of this published  study 
whether the onset of resolution of infection was the result 
of incomplete depletion of targeted CD4 + T  cells, because 
the results of cytofluorometric analysis at the time of resolu- 
tion of infection were not presented. In the case of the study 
presented here, repeated treatment with anti-CD4 mAb was 
shown to result in essentially complete depletion of CD4 + 
T  cells,  in  that  the treated mice possessed  only  1.2%  of 
the splenic CD4 + T  cells possessed by control mice at day 
40 of infection. However, because infection caused a large 
increase in the cellularity of the spleen, the 99% depletion 
of CD4 + T cells still left mice with 6  x  10  s of these T cells 
on day 40, a number that cannot be disregarded. It should 
be brought to mind in this connection, however, that, un- 
like the repertoire of B cells, which is based to an appreciable 
extent on somatic hypermutation in Ig V region genes, the 
repertoire of T cells is relatively fixed after immunologic matu- 
ration (18). Therefore, it is likely that few of the 0.3--0.4% 
CD4 +  T  cells  that  existed  in  anti-CD4-treated  thymec- 
tomized mice at the beginning of infection were specific for 
BCG. Indeed, because anti-CD4 mAb was given repeatedly 
during infection it should have resulted in the repeated de- 
struction of any CD4 + T  cells that multiplied in response 
to infection. Moreover, nude mice that are known to possess 
only very small absolute numbers of CD8 + and CD4 + T 
cells, presumably few of which are capable of expressing c~/~/ 
TCRs (7, 8) and of functioning normally in vivo (9, 10) or 
in vitro (11), gave the same results as T  cell-depleted mice. 
Therefore, the results support the interpretation that CD4 + 
T cells are not needed for stabilization of BCG infection in 
the liver, spleen, and kidneys after 2-3 wk of progressive BCG 
growth. These results with nude mice are in agreement with 
growth curves published some years ago by others, which 
on examination show that nude mice (19, 20) and neonatally 
thymectomized mice (17),  although incapable of resolving 
infection, were capable of restricting BCG growth to a con- 
siderable extent in their livers and spleen after a certain stage 
of infection. The results presented here showing that SCID 
mice engrafted with lymph node cells depleted of CD4 + T 
cells are capable of expressing a substantial level of anti-BCG 
resistance support  this conclusion. 
It needs to be emphasized that although mice depleted of 
CD4 + T  cells,  nude mice, and SCID mice engrafted with 
CD4 +  T  cell-depleted  lymphoid  cells  were  capable  of 
gaining control of BCG infection in their livers, spleens, and 
kidneys, they were much less capable of controlling infection 
in their lungs. Indeed, the results suggest that CD4 + T cells 
are essential for the control, as well as the resolution, of BCG 
infection in the lungs. This indicates that the c~/B T cell-in- 
dependent mechanism of resistance that exists in other organs 
may not exist in the lungs. In this regard it has been noted 
repeatedly over the years that the lung is the most suscep- 
tible organ to infection with BCG and M. tuberculosis (22). 
In  conclusion,  this  study draws  attention  to  the  anti- 
mycobacterial resistance that remains in mice in the absence 
of CD4 + and CD8 + T  cells,  rather than to the resistance 
that is lost.  Given that the resistance that remains is rela- 
tively powerful, and the possibility that it is mediated by'y//~ 
T  cells specific for mycobacterial antigens, it cannot be ig- 
nored in any analysis  of the cellular basis  of antimycobac- 
terial immunity. 
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